Brent Collett, a craniofacial specialist at the Seattle Children’s Research Institute wrote in an editorial in the BMJ that future studies, including larger samples, would be helpful in determining whether some infants respond more favourably than others. In particular, it would be of interest to learn whether children with the most severe positional plagiocephaly and brachycephaly, who were excluded from this trial, show meaningful improvement.
Ari Brown, a paediatrician from Texas said she sees an area for future research on children with more severe plagiocephaly. ‘This is where helmets make the most difference’.
The study reports that no infants with torticollis or dysmorphic features were included. However, many of the babies we see in our assessments have these clinical presentations and once again have not responded to repositioning and manual therapy techniques.
We also assess infants who have moderate-severe head shape deformities. Following assessment of each infant, correct repositioning advice is provided so that many of this group goes onto achieve natural correction without orthotic intervention.
It is reported that in neither group did the head shape normalise at the end of the trial and at 2 years old only about a quarter in both groups reached a normal head shape. We disagree, all infants we treat achieve statistically significant improvements to their head shapes and many progress to a head shape within the normal range at the end of their treatment.
Much was reported on the side effects of helmet treatment. Side effects of helmets are minimal and temporary. Skin irritation reported as the major side effect in the study is usually nothing more than a mild sweat rash where Sudocrem is all that is required to treat it. We discuss all possible side effects with parents at the beginning of the treatment so they are fully aware of what can happen before making a decision. Unfortunately, this has been hugely exaggerated in the press surrounding the research last week.